---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-024491"
form_type: "8-K"
ticker: "TELO"
cik: "0001971532"
company_name: "Telomir Pharmaceuticals, Inc."
filed_at: "2025-11-20T23:59:59+00:00"
generated_at: "2026-05-16T18:14:16.174392+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Telomir Pharmaceuticals director Craig Eagle resigns from board, effective Nov 14, 2025

## Summary
- Craig Eagle resigned from the Board of Directors on November 14, 2025, effective immediately.
- Resignation was not due to any disagreement with the Company, management, or other board members.
- The Board thanked Mr. Eagle for his service; no successor has been announced.
- Resignation letter attached as Exhibit 17.1 to the 8-K.

## SEC filing metadata
- accession: 0001493152-25-024491
- form_type: 8-K
- ticker: TELO
- cik: 0001971532
- company_name: Telomir Pharmaceuticals, Inc.
- filed_at: 2025-11-20T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1971532/000149315225024491/0001493152-25-024491-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1971532/000149315225024491/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-024491
- JSON: https://secwatch.observer/filing/0001493152-25-024491.json
- Plain text: https://secwatch.observer/filing/0001493152-25-024491.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.